F
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A109.7 KBFIVE PRIME THERAPEUTICS, INC.Feb 14, 6:26 PM ET·0001172661-22-000969
- SC 13G/A88.7 KBFIVE PRIME THERAPEUTICS, INC.May 17, 4:34 PM ET·0001104659-21-068163
- 8-K277.4 KBFIVE PRIME THERAPEUTICS, INC.Apr 16, 8:38 AM ET·0001193125-21-118566
- 8-K139.2 KBFIVE PRIME THERAPEUTICS, INC.Apr 15, 4:41 PM ET·0001193125-21-117841
- 10-K16.7 MBFIVE PRIME THERAPEUTICS, INC.Mar 22, 6:05 AM ET·0001564590-21-014463
- SC 13D102.8 KBFIVE PRIME THERAPEUTICS, INC.Mar 15, 6:33 AM ET·0001104659-21-035856
- SC 13G/A279.3 KBFIVE PRIME THERAPEUTICS, INC.Mar 8, 4:54 PM ET·0000921895-21-000675
- 8-K765.5 KBFIVE PRIME THERAPEUTICS, INC.Mar 4, 8:58 AM ET·0001193125-21-068593
- SC 13G109.8 KBFIVE PRIME THERAPEUTICS, INC.Mar 1, 5:00 PM ET·0001172661-21-000886
- SC 13G87.6 KBFIVE PRIME THERAPEUTICS, INC.Feb 16, 4:39 PM ET·0001104659-21-024224
Insiders
10- ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner
- Adage Capital Partners, L.P.10% Owner
- Atchinson Robert10% Owner
- ATWOOD BRIAN GDirector
- Baker Kevin PaulSVP, Development Sciences
- Belsky MarcVice President, Finance
- BERGER FRANKLIN MDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Borges LuisSVP, Research
Tickers
No tickers on record
Addresses
business
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080
mailing
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- FIVE PRIME THERAPEUTICS INC2019-08-02